☆ 4.7 Article

Unraveling the allosteric inhibition mechanism of PARP-1 CAT and the D766/770A mutation effects via Gaussian accelerated molecular dynamics and Markov state model

COMPUTERS IN BIOLOGY AND MEDICINE (2024)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemistry & Molecular Biology

Molecular Mechanism for the Allosteric Inhibition of the Human Serotonin Transporter by Antidepressant Escitalopram

Weiwei Xue et al.

Summary: This study explored the allosteric modulation mechanism of hSERT using two MD simulation strategies. The results showed that escitalopram enhanced its binding to the orthosteric site by binding to the allosteric site. Additionally, escitalopram occupying the allosteric site also blocked its dissociation from the orthosteric site. A new conformational coupling between extracellular and intracellular salt bridges was also identified. These findings are important for understanding the allosteric modulations of not only hSERT but also other clinically important therapeutic targets.

ACS CHEMICAL NEUROSCIENCE (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Captured snapshots of PARP1 in the active state reveal the mechanics of PARP1 allostery

Elise Rouleau-Turcotte et al.

Summary: PARP1 can rapidly detect DNA strand break damage and activate the production of poly(ADP-ribose) by signaling break detection to its catalytic domain. This study provides insights into the contributions of the regulatory helical domain (HD) to PARP1 allostery and the interaction with DNA damage, as well as the mechanisms of PARP1 catalytic activation and retention on DNA damage.

MOLECULAR CELL (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Discovery of novel anti-tumor compounds targeting PARP-1 with induction of autophagy through in silico and in vitro screening

Danfeng Shi et al.

Summary: This study aims to identify novel anti-tumor compounds targeting PARP-1 using computer simulations and in vitro screening. Two compounds were discovered that target PARP-1 and induce autophagy, providing potential hit compounds for anti-cancer drug development.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Selectively targeting individual bromodomain: Drug discovery and molecular mechanisms

Qianqian Wang et al.

Summary: Research has shown that although bromodomain-containing proteins exhibit high structural similarity, individual bromodomains have distinct functions and can lead to different cellular phenotypes after pharmacological inhibition. Significant progress has been made in developing bromodomain-selective inhibitors targeting BET and non-BET proteins, enriching the knowledge base for bromodomain-selective drug discovery.

PHARMACOLOGICAL RESEARCH (2021)

添加到收藏夹

Review Medicine, Research & Experimental

Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases

Komal Thapa et al.

Summary: This review discussed the role of PARP-1 in neurodegenerative diseases and various FDA-approved PARP-1 inhibitors. Studies have shown that targeting PARP with chemical inhibitors may have therapeutic outcomes in neurodegenerative diseases.

LIFE SCIENCES (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Dynamics of the HD regulatory subdomain of PARP-1; substrate access and allostery in PARP activation and inhibition

Tom E. H. Ogden et al.

Summary: PARP-1 is a key responder to DNA damage in eukaryotic cells, with an allosteric mechanism linking initial sensing of DNA breaks to activation of the catalytic domain. The HD subdomain of the catalytic domain is a key component in transmitting the allosteric signal, bridging between DNA-binding domains and the active site. This study uses NMR experiments to analyze dynamics and structures of the CAT domain, providing insights into the activation mechanism of PARP-1.

NUCLEIC ACIDS RESEARCH (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Rapid Detection and Signaling of DNA Damage by PARP-1

Nootan Pandey et al.

Summary: PARP-1 is an abundant ADP-ribosyl transfer-ase that plays a key role in DNA damage response. Novel PARP inhibitors can now be designed to treat cell toxicity caused by PARP-1 trapping on DNA.

TRENDS IN BIOCHEMICAL SCIENCES (2021)

添加到收藏夹

Review Genetics & Heredity

PARP1: Structural insights and pharmacological targets for inhibition

Jacob O. Spiegel et al.

Summary: PARP1 is a multifunctional enzyme involved in DNA repair pathways. Pharmacological inhibition of PARP1 is used to treat certain cancers, but resistance is common, highlighting the need for novel therapeutic approaches.

DNA REPAIR (2021)

添加到收藏夹

Article Chemistry, Medicinal

Molecular Mechanism of Ca2+in the Allosteric Regulation of Human Parathyroid Hormone Receptor-1

Mengrong Li et al.

Summary: Extensive molecular dynamics simulations of PTH1R-PTH complexes reveal that Ca2+ ions play a crucial role in regulating PTH1R activation through interactions with specific acidic residues, inducing protein conformational changes, and enhancing residue-residue communication.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)

添加到收藏夹

Article Chemistry, Physical

Exploring the thermodynamic, kinetic and inhibitory mechanisms of 5-iTU targeting mitotic kinase haspin by integrated molecular dynamics

Qianqian Wang et al.

Summary: This study applied integrated molecular dynamics techniques to investigate the characteristics of 5-iTU and its derivatives targeting haspin, revealing the crucial role of 5-iTU in binding with haspin and the importance of gatekeeper Phe605.

PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Subtype-selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors

Ting-ting Fu et al.

Summary: This study utilized computational modeling approaches to reveal the subtype-selective mechanism of mGlu(1) and mGlu(5) receptors to different drug scaffolds, identifying critical residues that affect the binding of selective NAMs to the receptors. The results of this study can guide the rational design of novel NAMs.

ACTA PHARMACOLOGICA SINICA (2021)

添加到收藏夹

Article Oncology

Compound C620-0696, a new potent inhibitor targeting BPTF, the chromatin-remodeling factor in non-small-cell lung cancer

Jiahui Xu et al.

FRONTIERS OF MEDICINE (2020)

添加到收藏夹

Article Oncology

Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models

Janice M. Santiago-O'Farrill et al.

CANCER (2020)

添加到收藏夹

Article Chemistry, Physical

ff19SB: Amino-Acid-Specific Protein Backbone Parameters Trained against Quantum Mechanics Energy Surfaces in Solution

Chuan Tian et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Structural basis for allosteric PARP-1 retention on DNA breaks

Levani Zandarashvili et al.

SCIENCE (2020)

添加到收藏夹

Review Chemistry, Medicinal

The ups and downs of Poly(ADP-ribose) Polymerase-1 inhibitors in cancer therapy-Current progress and future direction

Yue Zhao et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

添加到收藏夹

Review Chemistry, Multidisciplinary

End-Point Binding Free Energy Calculation with MM/PBSA and MM/GBSA: Strategies and Applications in Drug Design

Ercheng Wang et al.

CHEMICAL REVIEWS (2019)

添加到收藏夹

Article Chemistry, Multidisciplinary

Refined Empirical Force Field to Model Protein-Self-Assembled Monolayer Interactions Based on AMBER14 and GAFF

Pratiti Bhadra et al.

LANGMUIR (2019)

添加到收藏夹

Article Chemistry, Medicinal

Discovery of novel functionalized 1,2,4-triazoles as PARP-1 inhibitors in breast cancer: Design, synthesis and antitumor activity evaluation

Ahmed T. A. Boraei et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

添加到收藏夹

Review Chemistry, Medicinal

Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update

Priyancy G. Jain et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

添加到收藏夹

Article Oncology

PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow

Todd A. Hopkins et al.

MOLECULAR CANCER RESEARCH (2019)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders

Robert J. Henning et al.

CARDIOVASCULAR TOXICOLOGY (2018)

添加到收藏夹

Article Oncology

FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy

Gwynn Ison et al.

CLINICAL CANCER RESEARCH (2018)

添加到收藏夹

Article Oncology

Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial

Sibylle Loibl et al.

LANCET ONCOLOGY (2018)

添加到收藏夹

Review Pharmacology & Pharmacy

Targeting NAD(+) degradation: The therapeutic potential of flavonoids for Alzheimer's disease and cognitive frailty

Qingwei Ruan et al.

PHARMACOLOGICAL RESEARCH (2018)

添加到收藏夹

Review Pharmacology & Pharmacy

Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases

Nathan A. Berger et al.

BRITISH JOURNAL OF PHARMACOLOGY (2018)

添加到收藏夹

Article Chemistry, Medicinal

Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors

Ann-Gerd Thorsell et al.

JOURNAL OF MEDICINAL CHEMISTRY (2017)

添加到收藏夹

Review Cell Biology

PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes

Rebecca Gupte et al.

GENES & DEVELOPMENT (2017)

添加到收藏夹

Article Oncology

Smoking History Predicts Sensitivity to PARP Inhibitor Veliparib in Patients with Advanced Non-Small Cell Lung Cancer

Martin Reck et al.

JOURNAL OF THORACIC ONCOLOGY (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Progression through mitosis promotes PARP inhibitor-induced cytotoxicity in homologous recombination-deficient cancer cells

Pepijn M. Schoonen et al.

NATURE COMMUNICATIONS (2017)

添加到收藏夹

Article Cell Biology

Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action

Yves Pommier et al.

SCIENCE TRANSLATIONAL MEDICINE (2016)

添加到收藏夹

Article Oncology

A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation - An NRG Oncology/Gynecologic Oncology Group study

Robert L. Coleman et al.

GYNECOLOGIC ONCOLOGY (2015)

添加到收藏夹

Article Chemistry, Physical

Gaussian Accelerated Molecular Dynamics: Unconstrained Enhanced Sampling and Free Energy Calculation

Yinglong Miao et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)

添加到收藏夹

Article Chemistry, Physical

PyEMMA 2: A Software Package for Estimation, Validation, and Analysis of Markov Models

Martin K. Scherer et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)

添加到收藏夹

Article Oncology

Poly (ADP-Ribose) Polymerase Inhibitors: Recent Advances and Future Development

Clare L. Scott et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

添加到收藏夹

Article Biochemistry & Molecular Biology

PARP-1 Activation Requires Local Unfolding of an Autoinhibitory Domain

Jennine M. Dawicki-McKenna et al.

MOLECULAR CELL (2015)

添加到收藏夹

Article Biochemistry & Molecular Biology

Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy

Jean-Remy Marchand et al.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2014)

添加到收藏夹

Article Biochemistry & Molecular Biology

Markov state models of biomolecular conformational dynamics

John D. Chodera et al.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2014)

添加到收藏夹

Article Chemistry, Physical

Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set

Huiyong Sun et al.

PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2014)

添加到收藏夹

Article Cell Biology

ARTD1/PARP1 Negatively Regulates Glycolysis by Inhibiting Hexokinase 1 Independent of NAD+ Depletion

Elise Fouquerel et al.

CELL REPORTS (2014)

添加到收藏夹

Article Chemistry, Physical

Slow dynamics of a protein backbone in molecular dynamics simulation revealed by time-structure based independent component analysis

Yusuke Naritomi et al.

JOURNAL OF CHEMICAL PHYSICS (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Structural Basis for DNA Damage-Dependent Poly(ADP-ribosyl)ation by Human PARP-1

Marie-France Langelier et al.

SCIENCE (2012)

添加到收藏夹

Article Chemistry, Physical

Markov models of molecular kinetics: Generation and validation

Jan-Hendrik Prinz et al.

JOURNAL OF CHEMICAL PHYSICS (2011)

添加到收藏夹

Article Chemistry, Physical

Probing molecular kinetics with Markov models: metastable states, transition pathways and spectroscopic observables

Jan-Hendrik Prinz et al.

PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2011)

添加到收藏夹

Review Biochemistry & Molecular Biology

Toward a unified nomenclature for mammalian ADP-ribosyltransferases

Michael O. Hottiger et al.

TRENDS IN BIOCHEMICAL SCIENCES (2010)

添加到收藏夹

Article Mathematics, Applied

Robust Perron cluster analysis in conformation dynamics

P Deuflhard et al.

LINEAR ALGEBRA AND ITS APPLICATIONS (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.